438 related articles for article (PubMed ID: 30107313)
21. Hepatitis C testing and treatment uptake among young people who use opioids in New York City: A cross-sectional study.
Kapadia SN; Katzman C; Fong C; Eckhardt BJ; Guarino H; Mateu-Gelabert P
J Viral Hepat; 2021 Feb; 28(2):326-333. PubMed ID: 33141503
[TBL] [Abstract][Full Text] [Related]
22. Underreported injection drug use and its potential contribution to reported increase in sexual transmission of HIV in Kazakhstan and Kyrgyzstan.
Deryabina AP; Patnaik P; El-Sadr WM
Harm Reduct J; 2019 Jan; 16(1):1. PubMed ID: 30611251
[TBL] [Abstract][Full Text] [Related]
23. Risky behavior and correlates of HIV and Hepatitis C Virus infection among people who inject drugs in three cities in Afghanistan.
Ruiseñor-Escudero H; Wirtz AL; Berry M; Mfochive-Njindan I; Paikan F; Yousufi HA; Yadav RS; Burnham G; Vu A
Drug Alcohol Depend; 2014 Oct; 143():127-33. PubMed ID: 25131717
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and risk factors associated with HIV-1 infection among people who inject drugs in Dar es Salaam, Tanzania: a sign of successful intervention?
Likindikoki SL; Mmbaga EJ; Leyna GH; Moen K; Makyao N; Mizinduko M; Mwijage AI; Faini D; Leshabari MT; Meyrowitsch DW
Harm Reduct J; 2020 Mar; 17(1):18. PubMed ID: 32209110
[TBL] [Abstract][Full Text] [Related]
25. Correlates of anti-hepatitis C positivity and use of harm reduction services among people who inject drugs in two cities in Croatia.
Handanagic S; Sevic S; Barbaric J; Dominkovic Z; Dakovic Rode O; Begovac J; Bozicevic I
Drug Alcohol Depend; 2017 Feb; 171():132-139. PubMed ID: 28088084
[TBL] [Abstract][Full Text] [Related]
26. Prospects for ending the HIV epidemic among persons who inject drugs in Haiphong, Vietnam.
Des Jarlais DC; Thi Huong D; Thi Hai Oanh K; Khuê Pham M; Thi Giang H; Thi Tuyet Thanh N; Arasteh K; Feelemyer J; Hammett T; Peries M; Michel L; Vu Hai V; Roustide MJ; Moles JP; Laureillard D; Nagot N;
Int J Drug Policy; 2016 Jun; 32():50-6. PubMed ID: 27006257
[TBL] [Abstract][Full Text] [Related]
27. Has resourcing of non-governmental harm-reduction organizations in Ukraine improved HIV prevention and treatment outcomes for people who inject drugs? Findings from multiple bio-behavioural surveys.
Trickey A; Semchuk N; Saliuk T; Sazonova Y; Varetska O; Walker JG; Lim AG; Stone J; Vickerman P
J Int AIDS Soc; 2020 Aug; 23(8):e25608. PubMed ID: 32851812
[TBL] [Abstract][Full Text] [Related]
28. Estimating HIV and HCV prevalence among people who inject drugs in 5 Ukrainian cities using stratification-based respondent driven and random sampling.
Zelenev A; Shea P; Mazhnaya A; Meteliuk A; Pykalo I; Marcus R; Fomenko T; Prokhorova T; Altice FL
Int J Drug Policy; 2019 May; 67():91-101. PubMed ID: 30503695
[TBL] [Abstract][Full Text] [Related]
29. Trends in sources and sharing of needles among people who inject drugs, San Francisco, 2005-2012.
Kim NJ; Jin H; McFarland W; Raymond HF
Int J Drug Policy; 2015 Dec; 26(12):1238-43. PubMed ID: 26365768
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and correlates of HCV monoinfection and HIV and HCV coinfection among persons who inject drugs in Vietnam.
Zhang L; Celentano DD; Le Minh N; Latkin CA; Mehta SH; Frangakis C; Ha TV; Mo TT; Sripaipan T; Davis WW; Quan VM; Go VF
Eur J Gastroenterol Hepatol; 2015 May; 27(5):550-6. PubMed ID: 25769097
[TBL] [Abstract][Full Text] [Related]
31. HIV prevalence and risk among people who inject drugs in five South African cities.
Scheibe A; Makapela D; Brown B; dos Santos M; Hariga F; Virk H; Bekker LG; Lyan O; Fee N; Molnar M; Bocai A; Eligh J; Lehtovuori R
Int J Drug Policy; 2016 Apr; 30():107-15. PubMed ID: 26860326
[TBL] [Abstract][Full Text] [Related]
32. High prevalence of human immunodeficiency virus, hepatitis B and C viral infections among people who inject drugs: a potential stumbling block in the control of HIV and viral hepatitis in Tanzania.
Kawambwa RH; Majigo MV; Mohamed AA; Matee MI
BMC Public Health; 2020 Feb; 20(1):177. PubMed ID: 32019536
[TBL] [Abstract][Full Text] [Related]
33. Role of direct and indirect social and spatial ties in the diffusion of HIV and HCV among people who inject drugs: a cross-sectional community-based network analysis in New Delhi, India.
Clipman SJ; Mehta SH; Srikrishnan AK; Zook KJ; Duggal P; Mohapatra S; Shanmugam S; Nandagopal P; Kumar MS; Ogburn E; Lucas GM; Latkin CA; Solomon SS
Elife; 2021 Aug; 10():. PubMed ID: 34342266
[TBL] [Abstract][Full Text] [Related]
34. Potential geographic "hotspots" for drug-injection related transmission of HIV and HCV and for initiation into injecting drug use in New York City, 2011-2015, with implications for the current opioid epidemic in the US.
Des Jarlais DC; Cooper HLF; Arasteh K; Feelemyer J; McKnight C; Ross Z
PLoS One; 2018; 13(3):e0194799. PubMed ID: 29596464
[TBL] [Abstract][Full Text] [Related]
35. High regional variability of HIV, HCV and injecting risks among people who inject drugs in Poland: comparing a cross-sectional bio-behavioural study with case-based surveillance.
Rosińska M; Sierosławski J; Wiessing L
BMC Infect Dis; 2015 Feb; 15():83. PubMed ID: 25879904
[TBL] [Abstract][Full Text] [Related]
36. Comparing risk environments for HIV among people who inject drugs from three cities in Northern Mexico.
Ospina-Escobar A; Magis-Rodríguez C; Juárez F; Werb D; Bautista Arredondo S; Carreón R; Ramos ME; Strathdee S
Harm Reduct J; 2018 May; 15(1):27. PubMed ID: 29776368
[TBL] [Abstract][Full Text] [Related]
37. Investigating the sociodemographic and behavioural factors associated with hepatitis C virus testing amongst people who inject drugs in England, Wales and Northern Ireland: A quantitative cross-sectional analysis.
Yuan JM; Croxford S; Viviani L; Emanuel E; Phipps E; Desai M
Int J Drug Policy; 2022 Nov; 109():103821. PubMed ID: 35994940
[TBL] [Abstract][Full Text] [Related]
38. Understanding differences in HIV/HCV prevalence according to differentiated risk behaviors in a sample of PWID in rural Puerto Rico.
Abadie R; Welch-Lazoritz M; Gelpi-Acosta C; Reyes JC; Dombrowski K
Harm Reduct J; 2016 Mar; 13():10. PubMed ID: 26956029
[TBL] [Abstract][Full Text] [Related]
39. Prevalence and risk factors for injection site skin infections among people who inject drugs (PWID) in Tehran.
Noroozi M; Armoon B; Ghisvand H; Noroozi A; Karimy M; Bazrafshan MR; Marshall BDL; Dieji B
J Cosmet Dermatol; 2019 Feb; 18(1):258-262. PubMed ID: 29781249
[TBL] [Abstract][Full Text] [Related]
40. Differences in risk behaviours and HIV status between primary amphetamines and opioid injectors in Estonia and Russia.
Tavitian-Exley I; Maheu-Giroux M; Platt L; Heimer R; Uusküla A; Levina O; Vickerman P; Boily MC
Int J Drug Policy; 2018 Mar; 53():96-105. PubMed ID: 29306786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
